COBAPHARMA is a pharmaceutical company specializing in the international business development and marketing of API, Finished Dosage Form, and advanced intermediates for the pharmaceutical and biotech industry. Founded in 2011, the company operates within the Biopharma and Pharmaceutical sectors, with a particular focus on bridging the gap between international markets and China.
With a strategic partnership that provides deep knowledge, experience, and local presence, COBAPHARMA has established a firm foothold in one of the largest pharmaceutical markets, facilitating access to substantial business opportunities. Despite the lack of disclosed information regarding the company's headquarter and last investment, COBAPHARMA's niche focus and international outlook position it as a prospective player in the growing pharmaceutical industry.
There is no investment information
No recent news or press coverage available for COBAPHARMA.
We care about your data, and we'd love to use cookies make your experience better.
